ZEALAND PHARMA

Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (“Zealand”) is a biotech company with leading-edge scientific expertise in turning peptides into medicines. Zealand has a growing proprietary pipeline of novel specialty drug candidates and a mature portfolio of products and projects under license collaborations with Sanofi, Helsinn Healthcare and Boehringer Ingelheim. Zealand’s first invented medicine, lixisenatide, a once-daily prandial GLP-1 analogue for the treatment of Type 2 diabetes, is ... marketed globally outside the US as Lyxumia:registered: by Sanofi and under regulatory review in the US. The license collaboration with Sanofi covers also a single-product combination of lixisenatide and insulin glargine (Lantus:registered:) which is on track for regulatory submission in the US in December 2015 and in the European Union in Q1 2016. The proprietary pipeline includes; danegaptide for ischemic reperfusion Injuries in Phase II development; ZP1848 for Short Bowel Syndrome in Phase II development; and the stable glucagon analogue, ZP4207, in Phase II preparation both as a single-dose rescue pen for severe hypoglycemia and for multiple-dose use to treat and control mild to moderate hypoglycemia; as well as several preclinical peptide therapeutics. The company is based in Copenhagen (Glostrup), Denmark. For further information about Zealand’s business and activities, please visit: www.zealandpharma.com or follow us on Twitter @ZealandPharma

#SimilarOrganizations #People #Financial #Event #Website #More

ZEALAND PHARMA

Social Links:

Twitter

Industry:

Biopharma Biotechnology Health Care

Founded:

1998-01-01

Address:

Copenhagen, Hovedstaden, Denmark

Country:

Denmark

Website Url:

http://www.zealandpharma.com

Total Employee:

101+

Status:

Active

Contact:

45 88 77 36 00

Email Addresses:

[email protected]

Total Funding:

271.52 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving

Similar Organizations

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

healx-logo

Healx

Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

Current Advisors List

remi-droller_image

Remi Droller Member of the Board of Directors @ Zealand Pharma
Board_member

martin-nicklasson_image

Martin Nicklasson Chairman @ Zealand Pharma
Board_member
2015-04-01

rosemary-crane_image

Rosemary Crane Vice Chairman @ Zealand Pharma
Board_member
2015-04-01

david-kendall_image

David Kendall Senior Global Medical Advisor @ Zealand Pharma
Advisor
2020-08-01

alain-munoz_image

Alain Munoz Board member @ Zealand Pharma
Board_member
2007-01-01

Current Employees Featured

andrew-parker_image

Andrew Parker
Andrew Parker Chief Scientific Officer, Executive Vice-President, Head of Research & External Innovation @ Zealand Pharma
Chief Scientific Officer, Executive Vice-President, Head of Research & External Innovation
2016-07-01

marie-skovgaard_image

Marie Skovgaard
Marie Skovgaard Director of Medicinal Chemistry @ Zealand Pharma
Director of Medicinal Chemistry
2016-03-01

daan-ellens_image

Daan Ellens
Daan Ellens Chairman of the Supervisory Board @ Zealand Pharma
Chairman of the Supervisory Board

pernille-tofteng-shelton_image

Pernille Tofteng Shelton
Pernille Tofteng Shelton Senior Scientist @ Zealand Pharma
Senior Scientist
2014-01-01

not_available_image

Matt Dallas
Matt Dallas Chief Financial Officer @ Zealand Pharma
Chief Financial Officer

not_available_image

Lars Hellerung Christiansen
Lars Hellerung Christiansen Co-Founder @ Zealand Pharma
Co-Founder
1998-01-01

matthew-nguyen_image

Matthew Nguyen
Matthew Nguyen Vice President @ Zealand Pharma
Vice President
2020-04-01

adam-steensberg_image

Adam Steensberg
Adam Steensberg Chief Executive Officer @ Zealand Pharma
Chief Executive Officer
2022-03-01

eva-steiness_image

Eva Steiness
Eva Steiness Founder @ Zealand Pharma
Founder

not_available_image

Dr. Bjarne Due Larsen
Dr. Bjarne Due Larsen Founder @ Zealand Pharma
Founder
1998-01-01

Founder

not_available_image

Dr. Bjarne Due Larsen

eva-steiness_image

Eva Steiness

not_available_image

Lars Hellerung Christiansen

Stock Details

Company's stock symbol is NASDAQ:ZEAL

Acquisitions List

Date	Company	Article	Price
2020-02-10	Valeritas	Valeritas acquired by Zealand Pharma	23 M USD
2019-10-23	Encycle Therapeutics	Encycle Therapeutics acquired by Zealand Pharma	N/A

Investors List

oberland-capital_image

Investments List

Date	Company	Article	Money raised
2019-01-08	Beta Bionics	Zealand Pharma investment in Series B - Beta Bionics	63 M USD

Key Employee Changes

Date	New article
2022-08-24	Zealand Pharma Appoints Henriette Wennicke as Chief Financial Officer
2022-06-02	Zealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Officer
2022-03-30	Zealand Pharma Appoints New Chief Executive Officer, Refocuses Strategy to Prioritize Research & Development and Streamlines Operations

Official Site Inspections

http://www.zealandpharma.com Semrush global rank: 2.14 M Semrush visits lastest month: 9.44 K

Host Informations
Whois Informations

Loading ...